NCT06980571View on ClinicalTrials.gov

Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Liver Disease
Interventions
DEVICE

radiofrequency ablation

FDA approved intervention being compared with gold standard (most common intervention)

Trial Locations (1)

E1 1BB

Royal London Hospital, London

All Listed Sponsors
lead

Barts & The London NHS Trust

OTHER

NCT06980571 - Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections | Biotech Hunter | Biotech Hunter